Skip to main content

Summit Therapeutics Inc.

SMMT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001599298

No open-market purchases or sales by Summit Therapeutics Inc. insiders were filed in the last 90 days; 242 institutions reported holding it in 13F filings for Q2 2026, worth $1.98B in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Summit Therapeutics Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of SMMT: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders2222242+22
Shares118.9M13.1K135.9M+17.0M (+14.3%)
Value$2.25B$249.1K$1.98B−$272.3M (−12.1%)

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (57)

Institutions that held Summit Therapeutics Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to SMMT in Q2 2026
InstitutionSharesValue% of portfolio
Adage Capital Partners GP, L.L.C.1,989,591$29.0M0.04%
Norges Bank1,382,519$20.1M0.00%
Logos Global Management LP1,350,000$19.7M0.85%
Octagon Capital Advisors LP1,250,000$18.2M1.67%
Kynam Capital Management, LP1,200,000$17.5M0.97%
Elmind Capital, LP493,820$7.19M1.81%
Ghisallo Capital Management LLC350,000$5.10M0.10%
Hohimer Wealth Management, LLC339,100$4.94M0.51%
HRT Financial LP197,653$2.88M0.01%
Trexquant Investment LP184,013$2.68M0.02%
HSBC Holdings PLC120,560$1.78M0.00%
Caption Management, LLC100,000$1.46M0.05%
XTX Topco Ltd81,402$1.19M0.02%
Seven Fleet Capital Management LP73,300$1.09M0.18%
Nicolet Bankshares Inc72,593$1.06M0.03%
Engineers Gate Manager LP67,871$988.9K0.01%
Bridgefront Capital, LLC60,416$880.3K0.23%
Diadema Partners LP60,000$874.2K0.31%
Hudson Bay Capital Management LP54,950$800.6K0.00%
Brevan Howard Capital Management LP45,164$658.0K0.01%
CWM Advisors, LLC36,609$533.4K0.02%
State of Wyoming35,973$524.1K0.05%
TCG Advisory Services, LLC30,197$440.0K0.01%
Cinctive Capital Management LP29,871$435.2K0.02%
Summit Trail Advisors, LLC25,585$372.8K0.00%
Aigen Investment Management, LP24,477$356.6K0.10%
LPL Financial LLC22,261$324.3K0.00%
Excelsior Advisor Network LLC17,975$261.9K0.03%
nVerses Capital, LLC17,749$258.6K0.40%
Bayesian Capital Management, LP17,200$250.6K0.16%
New World Advisors LLC16,361$238.4K0.04%
Persistent Asset Partners Ltd15,312$223.1K0.07%
Janney Montgomery Scott LLC12,562$183.0K0.00%
Two Sigma Securities, LLC12,491$182.0K0.02%
Graham Capital Management, L.P.11,987$174.7K0.00%
Blackstone Group Inc.11,754$171.3K0.00%
Gsa Capital Partners LLP11,423$166.0K0.01%
SummitTX Capital, L.P.10,809$157.5K0.00%
Mackenzie Financial Corp10,442$152.1K0.00%
Sage Mountain Advisors LLC10,000$145.7K0.01%
Nykredit A/S7,634$111.2K0.00%
Caitong International Asset Management Co., Ltd5,536$80.7K0.01%
Pacer Advisors, Inc.3,451$50.0K0.00%
Ossiam733$10.7K0.00%
Global Retirement Partners, LLC686$9.99K0.00%
Rialto Wealth Management, LLC396$5.78K0.00%
Zions Bancorporation, National Association132$1.92K0.00%
Northwestern Mutual Wealth Management Co122$1.78K0.00%
Rossby Financial, LCC53$7720.00%
Manchester Capital Management LLC43$6270.00%
UMA Financial Services, Inc.35$5100.00%
Allied Private Wealth LLC30$4700.00%
Silver Grove Financial Group, Inc.23$3350.00%
Bartlett & Co. Wealth Management LLC11$1600.00%
Ameriflex Group, Inc.6$870.00%
SJS Investment Consulting Inc.1$150.00%
Avion Wealth29$00.00%

Sold out (35)

Institutions that held Summit Therapeutics Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Not filed for Q2 2026 yet (2)

Institutions that held Summit Therapeutics Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SMMT in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
U.S. Capital Wealth Advisors, LLC12,009$227.7K
CWM, LLC1,131$21.4K